Topic: drug shortage

Healthcare management company Premier has set up a new subsidiary to focus on helping providers with drug shortages.

Hospitals can expect ongoing shortages of some key drugs as Pfizer continues to work on its troubled sterile injectables plant.

GlaxoSmithKline has had a Shingrix shortage for months, but now Sen. Schumer said the government shutdown is making the situation worse.

The American Hospital Association has crafted a lengthy list of suggestions for addressing drug shortages that include both the carrot and the stick.

The FDA’s Center for Veterinary Medicine has reached an agreement for Pfizer to divert part of a new source of injected pain drugs to veterinarians.

Here is some other vaccine news of note for the week.

Mylan, Pfizer and the FDA notified U.S. healthcare providers of a potential problem with some EpiPens which can delay treatment.

Manufacturing issues at a CMO and a missed forecast by Merck have led to a shortage of some of its Parkinson’s disease drug Sinemet.

A hospital-backed group, Civica Rx intends to manufacture or contract the production of 14 drugs that are in chronic supply.

Privately held Kaléo has a supply of epinephrine auto injectors and is making sure the public knows its version is available.